Advocacy intelligence hub — real-time data for patient organizations
Dorothy Bautista, MD — PHASE3
Indiana Hemophilia &Thrombosis Center, Inc.
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Ryplazim
ProMetic BioTherapeutics, Inc.
Ryplazim
(plasminogen, human-tvmh)Orphan drugstandardProMetic BioTherapeutics, Inc.
Amy D Shapiro, MD
Indiana Hemophilia &Thrombosis Center, Inc.
Amy Shapiro, MD
Indiana Hemophilia & Thrombosis Center
Flora Peyvandi, MD, PhD
Univeristy of Milan
Charles Nakar, MD
Indiana Hemophilia & Thrombosis Center
📍 INDIANAPOLIS, IN
Roberto Crea
Kedrion S.p.A
Jeremy Lorber, MD
Tower Hematology, Oncology
📍 BEVERLY HILLS, CA